Previous Article | Next Article 
J Virol, August 1998, p. 6657-6664, Vol. 72, No. 8
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Steady-State Plasma Membrane Expression of Human
Cytomegalovirus gB Is Determined by the Phosphorylation State
of Ser900
Kenneth N.
Fish,
Cecilia
Soderberg-Naucler,
and
Jay A.
Nelson*
Department of Molecular Microbiology and
Immunology, Oregon Health Sciences University, Portland, Oregon
97201
Received 13 February 1998/Accepted 23 April 1998
 |
ABSTRACT |
Human cytomegalovirus (HCMV) infection of an astrocytoma cell line
(U373) or human fibroblast (HF) cells results in a differential cell
distribution of the major envelope glycoprotein gB (UL55). This
906-amino-acid type I glycoprotein contains an extracellular domain
with a signal sequence, a transmembrane domain, and a 135-amino-acid cytoplasmic tail with a consensus casein kinase II (CKII) site located
at Ser900. Since phosphorylation of proteins in the
secretory pathway is an important determinant of intracellular
trafficking, the state of gB phosphorylation in U373 and HF cells was
examined. Analysis of cells expressing wild-type gB and gB with
site-specific mutations indicated that the glycoprotein was equally
phosphorylated at a single site, Ser900, in both U373 and
HF cells. To assess the effect of charge on gB surface expression in
U373 cells, Ser900 was replaced with an aspartate (Asp) or
alanine (Ala) residue to mimic the phosphorylated and nonphosphorylated
states, respectively. Expression of the Asp but not the Ala gB mutation
resulted in an increase in the steady-state expression of gB at the
plasma membrane (PM) in U373 cells. In addition, treatment of U373
cells with the phosphatase inhibitor tautomycin resulted in the
accumulation of gB at the PM. Interestingly, the addition of a charge
at Ser900 trapped gB in a low-level cycling pathway at the
PM, preventing trafficking of the protein to the
trans-Golgi network or other intracellular compartments.
Therefore, these results suggest that a tautomycin-sensitive
phosphatase regulates cell-specific PM retrieval of gB to intracellular
compartments.
 |
INTRODUCTION |
Viral glycoproteins mediate a
number of essential functions in the virus life cycle, including
entry into the host cell, assembly of viral progeny, and release of
infectious virus (24). Glycoprotein maturation occurs
through posttranslational modification during sequential transport
through the cellular secretory pathway. Viral proteins use cellular
trafficking pathways to concentrate at a subcellular location at which
capsid envelopment is thought to occur. The mechanisms involved in the
localization of glycoproteins to sites of viral assembly are poorly
understood.
Human cytomegalovirus (HCMV), a member of the herpesvirus family,
demonstrates cell specificity for virus assembly and release (22). The mechanisms for virus assembly and egress are still unclear, although attachment of membrane-bound viral glycoproteins to
tegumented capsid is believed to play an important role in this
process. The most abundant glycoprotein detected in the HCMV virion
envelope is gB (UL55) (6). HCMV gB is synthesized as a
105-kDa polypeptide and processed into a highly glycosylated 130-kDa
precursor glycoprotein. After glycosylation, the gB precursor is
cleaved by furin to produce a heterodimer protein (gp55 and gp116)
(52). gB is a type I glycoprotein containing a signal sequence, an extracellular or luminal domain, a transmembrane (TM)
domain, and a 135-amino-acid cytoplasmic tail (5, 20, 38).
The cytoplasmic tail contains a consensus casein kinase II (CKII) site,
which is phosphorylated both in vitro and in vivo (1, 37,
55).
HCMV infects several different cell types in patients, including
monocytes, fibroblasts, endothelial cells, epithelial cells, and
stromal cells (8, 9, 11, 13, 18, 19, 23, 28, 32-34, 40, 41, 45,
47-51, 54, 56). However, the vast majority of studies on HCMV
replication in vitro have used human fibroblasts (HF). Examination of
viral replication in other cell types, such as monocyte-derived
macrophages (MDM) and endothelial cells, revealed significant
differences in the kinetics of viral replication, viral cytopathic
effect, and release of virus from the cell (16, 17, 25).
Interestingly, unlike infected HF, in which virus is readily recovered
from supernatants, HCMV infection of MDM resulted exclusively in the
accumulation of intracellular but not extracellular infectious virus,
which was sequestered in numerous intracellular vacuoles whose
membranes contained gB. In addition, comparison of HF and MDM by
confocal microscopy revealed the presence of gB at the plasma membrane
(PM) of HF but not MDM. These observations suggest cell-specific
pathways for gB intracellular trafficking.
The surface expression of viral glycoproteins is affected by their
steady-state expression, transport to the PM, and rates of
internalization from the cell surface. Deletion and point mutational analysis of the C-terminal domain of cell surface receptors and viral
glycoproteins has revealed sequence motifs, which are used by adapter
molecules to sort the proteins to coated pits, where they become
internalized. Internalization signals have been identified for several
cellular proteins, including furin, low-density lipoprotein receptor,
transferrin receptor, polymeric immunoglobulin (Ig) receptor, and
epidermal growth factor receptor. Comparison of the sequences of these
proteins indicates that a common structure, rather than sequence, is
necessary for internalization. Recent studies on viral glycoproteins
have uncovered how viruses have evolved to take advantage of this
regulated endocytosis pathway (42, 60).
Recent studies with furin have demonstrated that the state of
glycoprotein phosphorylation can affect the steady-state expression of
a protein at the PM. Since HCMV gB displayed cell-specific PM
expression, we examined the effect of gB phosphorylation on gB
trafficking in different cell types. Our results indicate that gB
displays a cell-specific steady-state expression of protein at the cell
surface, which is regulated by a tautomycin-sensitive phosphatase. In
addition, the presence of a charged residue at the phosphorylation
site, which mimics the phosphorylation state, results in gB vacuoles
that remain near the PM. These data suggest that the cell-specific
differences in surface expression of gB are due to altered states of gB
phosphorylation, which appears to be mediated by a tautomycin-sensitive
phosphatase.
 |
MATERIALS AND METHODS |
Isolation and culture of MDM.
MDM cultures were obtained by
stimulation of fresh peripheral blood mononuclear cells from the blood
of HCMV-seronegative donors with concanavalin A and cultured as
previously described (15, 25).
HCMV infection of HF, U373 cells, and MDM.
A recent isolate
of HCMV (Po) or the laboratory strain AD169 was used to infect HF, U373
cells, and primary cultures of MDM. The clinical viral isolate Po was
isolated from a transplant patient with HCMV disease, passaged through
HF, and stored at low passage number at
70°C (25).
Frozen samples from this stock were thawed and passaged three
additional times through HF before being used to infect MDM. Cell-free
supernatants from HCMV-infected HF were used to infect the different
cell cultures as previously described (15).
Expression of gB by VV infection in HF and U373 cells.
Vaccinia virus (VV) WR was used in these studies. Recombinant VV (RVV)
were constructed by a modification of a previously described method
(4, 57). The point mutants gBAla and
gBAsp were constructed by PCR with the amino-terminal
primer gBwt N-term (5'-TCGTCTGATGCATCCACGGCG-3')
and the carboxy terminal primer gBAla C-term
(5'-CTAGCTGAGCGGCCGCTCAGACGTTCTCTTCTTCGTCGGCGTCTTTC-3') or gBAsp C-term
(5'-CTAGCTGAGCGGCCGCTCAGACGTTCTCTTCTTCGTCGTCGTCTTTC-3'). The
PCR fragments from the PCR mutagenesis of AD169 gB were digested with
NsiI and NotI and cloned into an
EcoRI site in Rep4DegBwt, resulting in
Rep4DegBAla and Rep4DegBAsp. The
genotype of the new clones was confirmed by sequence analysis and
digestion with EcoRI. gB was excised from the Rep4De clones
with XhoI, and the resulting 2.7-kb fragments were cloned
into the VV insertion selection plasmid pZVneo (21) digested
with XhoI. The orientation was confirmed by StuI
and BglII restriction digest analysis and cycle sequencing.
Homologous recombination, selection, and partial purification of
recombinant viruses were performed as described by VanSlyke et al.
(57). RVV 1-12-11 was chosen for gBwt, 13-24-13 was chosen for gBAsp, and 25-36-33-38 was chosen for
gBAla expression in VV. Expression of gBwt and
the gB point mutation substitutions gBAla and
gBAsp was carried out essentially as described previously (4). In addition, a VV that expresses a dynamin
dominant-negative mutant (RVV dynK44A) (7) was
constructed as described above.
Immunocytochemistry.
Uninfected and HCMV-infected cells were
grown on chamber slides, fixed at different time points after infection
for 20 min at room temperature in buffered picric acid-paraformaldehyde
(2% paraformaldehyde, 15% buffered picric acid), and permeabilized with 0.3% Triton X-100 in phosphate-buffered saline. The cells were
blocked with 20% normal goat serum in phosphate-buffered saline and
incubated for 1 h at 37°C with a 1:100 dilution of one of the
following antibodies raised against HCMV gene products: a monoclonal
antibody to the N terminus (6) or a polyclonal antibody to
the C terminus of gB (the murine monoclonal antibody was a generous
gift from William Britt, University of Alabama, Birmingham, Ala.). The
polyclonal antibody to the C terminus of gB was generated by immunizing
New Zealand White rabbits with glutathione S-transferase
(GST)-gB C-terminal tail chimeric protein, where the entire
cytoplasmic tail of gB was fused to GST. Injections and boosts were
performed as previously described (27). Binding of primary
antibody was detected with secondary antibodies conjugated to
fluorescein isothiocyanate (FITC; Sigma Chemical Co., St. Louis, Mo.),
tetramethylrhodamine isothiocyanate (TRITC; Sigma), or cyanine-5 (Biological Detection Systems, Inc., Pittsburgh, Pa.) raised in the
appropriate species and visualized on a Leica confocal laser scanning
microscope equipped with a Leitz Fluorovert-FU microscope and
argon-krypton laser (CLSM AR/KR-Laser). The Slowfade Antifade kit
(Molecular Probes, Inc., Eugene, Oreg.) was used to ensure minimal
fluorescence fading.
In vitro phosphorylation of GST-gB constructs.
Fusions of
native and mutated gB cytoplasmic tails with GST were produced by PCR
amplification of the appropriate full-length gB construct in pZVneo
(see above) and cloned into the BamHI site of pGEX 3X
(Pharmacia). GST chimeras expressed in bacteria were used for in vitro
phosphorylation assays. GST-gB (1 µg) was incubated at 30°C for 20 min in the presence of 0.1 mM [
-32P]ATP (4,000 cpm/pmol) in a final volume of 30 µl. CKII (10 U; ICOS) was assayed
in 50 mM Tris (pH 7.2)-150 mM KCl-10 mM MgCl2. CKI (10 U;
ICOS) was assayed in 50 mM Tris (pH 7.5)-150 mM NaCl-60 mM
MgCl2.
In vivo phosphorylation of gB.
Confluent HF and U373 cells
(5 × 106) cultured in 75-mm2 flasks were
infected with RVV at a multiplicity of infection of 5 and incubated at
37°C. At 2 h postinfection (p.i.), the medium was replaced with
phosphate-free minimal essential medium (MEM; Gibco) supplemented with
5% dialyzed fetal bovine serum (FBS). At 3 h postinfection,
sodium [32P]orthophosphate (3 mCi/5 × 106 cells) was added to the medium and the mixture was
incubated for an additional 4 h. After being labeled, the cells
were harvested in 1 ml of cold radioimmunoprecipitation assay (RIPA)
buffer containing protease inhibitors. The lysates were clarified by
centrifugation at 16,000 × g for 10 min at 4°C in an
Eppendorf microcentrifuge. The supernatant was transferred to a new
tube containing 5 µl of mouse IgG and incubated on ice for 10 min
with continuous mixing. Protein A-Sepharose (20 µl) was added, and
the mixture was incubated on ice for 10 minutes with continuous mixing.
The samples were centrifuged, and the supernatant was transferred to a
new tube. The samples were exposed to 20 µl of protein A-Sepharose
again to clear the supernatant. The samples were then transferred to a
new tube containing 10 µl of gB 7-17 and incubated overnight at
4°C with continuous mixing. This step was followed by addition of 20 µl of protein A-Sepharose; the total mixture was incubated on ice for
2 h with continuous mixing.
Radiolabeling and surface biotinylation of gB.
Radiolabeling
and surface biotinylation were used to measure the relative amounts of
gB at the PM of U373 cells infected with RVV gBwt, gBAla,
or gBAsp. U373 cells infected with RVV gBwt, gBAla, or gBAsp were pulsed-labeled for 12 h with [35S]methionine and [35S]cysteine at
2 days p.i. After removal of the label, the cells were pulsed with
NHS-SS-biotin (no. 61105; Pierce, Rockford, Ill.) (stock of 200 mg/ml
of dimethyl sulfoxide) at 4°C. After a 1-h labeling period, the cells
were rinsed with Hanks balanced salt solution and prepared for sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis.
The cells were harvested in 1 ml of cold RIPA buffer containing
protease inhibitors. The lysates were clarified by centrifugation at
16,000 × g for 10 min at 4°C in an Eppendorf
microcentrifuge. Biotinylated protein was recovered from sample
supernatants by precipitation with 35 µl of a 50% slurry of
ImmunoPure immobilized avidin (Pierce), after which the beads were
washed. Biotinylated gB was eluted from the avidin beads by boiling in
50 µl of 20 mM Tris-HCl (pH 7.5)-100 mM NaCl-1% SDS buffer for 5 min. The samples were then centrifuged, and the supernatants were
transferred to new tubes containing 5 µl of mouse IgG and incubated
on ice for 10 min with continuous mixing. Protein A-Sepharose (20 µl)
was added, and the mixture was incubated on ice for 10 min with
continuous mixing. The samples were centrifuged, and the supernatants
were transferred to a new tube. The samples were exposed to 20 µl of
protein A-Sepharose again to clear the supernatant. The samples were
then transferred to a new tube containing 10 µl of gB 7-17 and
incubated overnight at 4°C with continuous mixing. This step was
followed by the addition of 20 µl of protein A-Sepharose; the total
mixture was incubated on ice for 2 h with continuous mixing. The
immunoprecipitated protein was then analyzed by SDS-PAGE.
Internalization experiment.
gB antibody uptake experiments
were performed in RVV gBwt- or RVV
gBAsp-infected U373 cells. At 6 h postinfection, mouse
anti-gB N-terminus antibody was added to the cells for 30 min. The
cells were then rinsed and incubated for a 30-min chase period followed by fixation. Nonpermeabilized cells were stained with a
cyanine-5-anti-mouse secondary conjugate, rinsed, permeabilized,
stained with a TRITC-anti-mouse secondary conjugate, rinsed again, and
exposed to rabbit anti-gB C-terminus antibody and then to an
FITC-anti-rabbit secondary conjugate.
 |
RESULTS |
Steady-state HCMV gB exhibits cell-specific differences in
intracellular trafficking.
Previous studies of HCMV-permissive
cells indicated that production of virus remained exclusively cell
associated in U373 cells and MDM, in contrast to HF, which generated
significant amounts of supernatant virus (references
14 and 15 and unpublished observations). Since gB is an essential part of the viral envelope, we
used confocal microscopy to examine gB accumulation and
compartmentalization in these cell types. In HCMV-infected HF, gB was
observed in cytoplasmic vacuoles as well as at the PM (Fig.
1A). However, in MDM as well as U373
cells, gB was not detected at the PM and was restricted to
intracellular vacuoles (Fig. 1B and C). Similar gB expression patterns
were obtained in HF and U373 cells infected with an RVV which expressed
wild-type gB (RVVgBwt) (see Fig. 4A and D). The cellular
differences in gB localization suggested alteration of the trafficking
patterns of this protein in these cells.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 1.
Confocal images of gB staining in HCMV-infected cells.
HF (A), U373 cells (B), and MDM (C) were infected with HCMV as
described in Materials and Methods. HF were fixed at 3 days p.i., U373
cells were fixed at 7 days p.i., and MDM were fixed at 14 days p.i. The
cells were permeabilized and stained with a monoclonal mouse anti-gB
antibody. Magnifications, ×294.
|
|
Phosphorylation of HCMV gB occurs only at Ser900.
Previous studies have demonstrated that phosphorylation within acidic
cluster motifs is an important determinant for protein sorting to
intracellular compartments. Recently, the CKII consensus sequence
sequence D-Sp900-D-E-E-E-N in the HCMV gB
carboxy-terminal tail was shown to be phosphorylated in vitro and in
vivo (60). However, other potential phosphorylation sites
within gB were not examined in this study. To address this issue, a
gB-GST fusion protein was constructed in which the entire
135-amino-acid gB tail was fused to GST (GST-gBwt) to
determine the ability of CKII to phosphorylate Ser900 in
the context of the entire gB cytoplasmic tail. In addition, the point
mutation Ser900 to Ala900
(GST-gBAla) was constructed as a fusion protein and used to
determine if CKII phosphorylation of Ser900 was specific
for this site in an in vitro phosphorylation experiment. As
demonstrated in Fig. 2A,
GST-gBwt was an efficient substrate for CKII whereas
replacement of Ser900 with Ala abolished phosphorylation.
To ensure stable expression of both GST-gBwt and
GST-gBAla, expression was analyzed on denaturing SDS-PAGE gels with Coomassie brilliant blue staining. Figure 2B shows that both
GST-gB chimeras are stably expressed in similar quantities. In
addition, neither phosphorus alone nor CKI plus phosphorus was able to
phosphorylate the gB tail; therefore, Ser900
phosphorylation was specific. Thus, the above experiments with point
mutations demonstrate that Ser900 is the only amino acid in
the gB tail that is phosphorylated by CKII in vitro.

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 2.
In vitro CKII phosphorylation of a GST-gB C-terminal
tail chimeric protein. A GST-gBwt or gBAla
C-terminal tail chimera was attached to microbeads and treated with
either CKII or CKI and [32P]orthophosphate followed by
magnetic bead purification and SDS-PAGE. (A) gBwt but not
gBAla was phosphorylated by CKII. However, neither of the
chimeric proteins was phosphorylated by CKI. (B) Both
GST-gBwt and GST-gBAla, were stably expressed
as determined by analysis by denaturing SDS-PAGE.
|
|
To determine whether gB is phosphorylated in vivo,
32P-labeled HF and U373 cells were infected with HCMV.
Immunoprecipitation of gB from HCMV-infected HF and U373 cell lysates
indicated that the protein is naturally phosphorylated in vivo in both
cell types (Fig. 3A). These results
suggest that the cell-specific differences in the presence of gB at the
PM of HF and U373 cells is not due to the inability of CKII to
phosphorylate the protein in either cell type. To determine whether gB
Ser900 is the only residue phosphorylated in vivo, U373
cells and HF were infected by RVV expressing either WT (RVV
gBWT) or gB containing Ser900 replaced with an
Ala residue (RVV gBAla). While infection of U373 cells and
HF with RVV gBWT resulted in phosphorylation of gB in both cell types, mutation of the Ser900 residue abrogated
phosphorylation of the glycoprotein (Fig. 3B). Therefore,
Ser900 is the only amino acid in gB that is phosphorylated
in both U373 cells and HF.

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 3.
gB is phosphorylated in HF and U373 cells in vivo.
HCMV-infected (A), RVV gBwt-infected (B), or RVV
gBAla-infected (B) HF and U373 cells were labeled with
inorganic 32P and then subjected to immunoprecipitation
with gB-specific rabbit antisera and a preimmune (pre.) control serum.
In vivo-phosphorylated gB was detected in HCMV- and RVV
gBwt-infected but not in RVV gBAla-infected HF
and U373 cells.
|
|
A charge at Ser900 results in cell surface expression
of gB in U373 cells.
RVV gBwt, RVV gBAla,
and a virus that expresses gB with a point mutation which replaces
Ser900 with an aspartate residue (RVV gBAsp)
were used to determine if the state of gB phosphorylation affects
intracellular routing. The mutants gBAla and
gBAsp, with point mutations, were generated to mimic the
nonphosphorylated and phosphorylated states of gB Ser900,
respectively. Western blot analysis of RVV gBwt-,
gBAla-, or gBAsp-infected HF revealed similar
levels of gB production (data not shown). In addition, the localization
of gB was evaluated by confocal microscopy in HF and U373 cells
infected with RVV gBwt, RVV gBAla, or RVV
gBAsp. gB was detected at the cell surface of HF infected
with RVV gBwt (Fig. 4A) but
not at the surface of U373 cells (Fig. 4D). Figures 4A and D show that
gB expressed by RVV gBwt retains the
differential expression pattern observed with gB expression in both
HCMV-infected HF and U373 cells, respectively. Infection of HF or U373
cells with RVV gBAla resulted in a cellular distribution of
gB similar to that due to infection with RVV gBwt (compare
Fig. 4A and B and compare Fig. 4D and E, respectively). In contrast,
when U373 cells were infected with RVV gBAsp, a substantial
amount of gB was detected at the cell surface (Fig. 4F). In addition,
RVV gBAsp infection of HF resulted in increased expression
of gB at the PM compared to that due to RVV gBwt infection
(compare Fig. 4A and C).

View larger version (106K):
[in this window]
[in a new window]
|
FIG. 4.
Subcellular localization of gB in HF and U373 cells.
Confocal images of gB staining of cells infected with RVV
gBwt, RVV gBAla, or RVV gBAsp were
obtained. (A to C) Infected HF; (D to F) infected U373 cells. The cells
were stained before permeabilization or at 4°C (representing surface
gB) with mouse anti-gB (green) and after permeabilization (representing
total gB) with mouse anti-gB (red). (A and D) RVV gBwt
infections; (B and E) RVV gBAla mutant infections; (C and
F) RVV gBAsp mutant infections. Surface gB staining is a
combination of prepermeabilization at 4°C and postpermeabilization
(yellow) (A, B, C, and F). (G and H) Confocal microscopy images
demonstrating the presence of gB in VV-infected cells. U373 cells were
infected with either RVV gBwt (G) or RVV gBAla
(H) and subsequently treated with the phosphatase inhibitor tautomycin.
The cells were stained with mouse antibody to gB prepermeabilization or
at 4°C (green) (surface gB) and with mouse antibody to gB
postpermeabilization (red) (total gB). The accumulation of gB
trafficking to the surface was observed only in the RVV
gBwt infection (yellow) (G). To demonstrate that transport
of gB to the cell surface is not affected by the state of
phosphorylation, we coinfected U373 cells with RVV gBwt
(I), RVV gBAsp (J), or RVV gBAla (K) and RVV
dynK44A. Magnifications, ×303 for panels A to F and I to K
and ×473 for panels G and H.
|
|
To analyze the overall expression of gB at the cell surface of U373
cell cultures, surface biotinylation of RVV gBwt-, RVV gBAla-, or RVV gBAsp-infected cell monolayers
was performed. Specifically, U373 cells infected with RVV
gBwt, RVV gBAla, or RVV gBAsp were pulse-labeled for 12 h with [35S]methionine and
[35S]cysteine at 2 days p.i. After removal of the label,
the cells were pulsed with NHS-SS-biotin at 4°C for 30 min.
Surface-biotinylated proteins were immunoprecipitated from culture
extracts with immobilized avidin. After the biotin-avidin complexes
were disrupted by boiling, immobilized avidin was cleared by
centrifugation. gB was then immunoprecipitated from the sample
supernatants with a monoclonal antibody and analyzed by SDS-PAGE.
Figure 5 demonstrates that substantially
more gBAsp than gBAla is detected at the
surface of U373 cells.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 5.
The steady-state cell surface expression of
gBAsp is greater than that of gBwt and
gBAla on the PM of U373 cells. U373 cells were infected
with RVV gBwt, RVV gBAla, or RVV
gBAsp and then subjected to surface biotinylation to
analyze differences in gB PM expression. Specifically,
35S-labeled U373 cells infected with RVV gBwt,
RVV gBAla, or RVV gBAsp were pulsed with
NHS-SS-biotin and the immunoprecipitated surface gB was analyzed by
SDS-PAGE. This figure demonstrates that substantially more
gBAsp than gBAla is detected at the surface of
U373 cells. These results support the hypothesis that a charge at
position 900 in the gB cytoplasmic tail increases surface expression in
U373 cells. c-term, C terminus.
|
|
These results suggest that phosphorylation of Ser900 plays
a key role in the trafficking of gB, since replacing Ser900
with a charged amino acid (Asp) allows surface expression in both U373 cells and HF. One possible explanation for these observations is that
the delivery of gB to the PM depends on the phosphorylation state.
Alternatively, the state of gB phosphorylation may regulate internalization or recycling at the PM.
Tautomycin treatment of U373 cells results in gBwt cell
surface expression.
The altered trafficking of gB in U373 cells
infected with gBAsp suggests that the phosphorylation state
of Ser900 may play an important role in gB trafficking.
However, the experiments described above indicate that gB is equally
phosphorylated in both HF and U373 cells. The phosphorylation of gB in
these cells may also be influenced by the presence of differential
phosphatase activities that regulate the phosphorylation state of gB.
To determine whether phosphatases regulate gB cell surface expression,
U373 cells infected with RVV gBwt or RVV gBAla
were treated with either the phosphatase inhibitor okadaic acid (100 nM; inhibitor of protein phosphatase 2A) or tautomycin (100 nM;
inhibitor of protein phosphatases 1 and 2A). While addition of okadaic
acid to RVV gBwt- and RVV gBAla-infected U373
cells had no effect on gB localization (data not shown), addition of
tautomycin to RVV gBwt-infected U373 cells resulted in gB
accumulation at the cell surface (Fig. 4G) whereas an accumulation of
gB was not detected in RVV gBAla-infected U373 cells
treated with the phosphatase inhibitor (Fig. 4H). These observations
suggest that the lack of cell surface expression of gB in U373 cells
compared to HF cells is due to a specific phosphatase activity.
Trafficking of gB to the PM is not dependent on the state of gB
phosphorylation.
To determine if gB without a charged residue at
position 900 trafficks to the PM, U373 cells were coinfected with the
RVVs described above, in addition to a VV construct that expresses a
dynamin dominant-negative mutant (RVV dynK44A). The dynamin mutation prevents dynamin-mediated transport of surface molecules back
to the cytoplasm by blocking clathrin-dependent endocytosis (7). Coinfection of U373 cells with RVV dynK44A
and RVV gBwt (Fig. 4I), RVV gBAsp (Fig. 4J), or
RVV gBAla (Fig. 4K) resulted in the accumulation of gB at
the PM in U373 cells. Surface gB expression was not observed in RVV
gBwt-infected U373 cells coinfected with VV expressing
wild-type dynamin (data not shown); therefore, expression of gB at the
cell PM is not the result of VV infection. These data indicate that
both phosphorylated and nonphosphorylated gB can traffic to the cell
surface. Furthermore, these observations indicate that the
internalization of gB from the PM occurs via a clathrin-dependent
pathway. These experiments support the hypothesis that gB trafficks to
the PM in a charge-independent manner and is then internalized from the
cell surface to an intracellular compartment at a cell-specific rate.
gBAsp remains near the PM upon internalization.
Antibody uptake studies were performed to determine if gB that is
internalized at the PM accumulates in cytoplasmic vacuoles. U373 cells
were infected with RVV gBwt for 6 h, and the live
cells were given a 30-min exposure to a monoclonal antibody specific for the N terminus of gB. After being rinsed, the cells were incubated for 30 min at 37°C, fixed, prepared for immunofluorescence analysis, and examined for antibody internalization by confocal microscopy. Expression of gBwt resulted in the accumulation of the
glycoprotein in cytoplasmic vacuoles (Fig.
6A). As a control, antibody to the HCMV
tegument protein pp65 was added in parallel experiments and did not
stain cells (data not shown). Interestingly, when cells were infected
with RVV gBAsp, gB was internalized but remained associated
with the PM (Fig. 6B). Thus, in U373 cells, gBwt is rapidly
endocytosed upon reaching the cell surface, sorted upon endocytosis,
and concentrated on the surface of vacuoles. In contrast, gBAsp internalizes but remains in small vacuoles at the PM.

View larger version (84K):
[in this window]
[in a new window]
|
FIG. 6.
Endocytosis and intracellular targeting of gB in U373
cells. gB antibody uptake experiments were performed in RVV
gBwt-infected (A) or RVV gBAsp-infected (B)
U373 cells. At 6 h p.i., mouse anti-gB N-terminus antibody was
applied to the cells for 30 min. The cells were then rinsed and
incubated for a 30-min chase period followed by fixation.
Nonpermeabilized cells were stained with a cyanine-5-anti-mouse
secondary conjugate (blue; stable surface gB), followed by rinsing,
permeabilization, and staining with a TRITC-anti-mouse secondary
conjugate (red; internalized gB). The cells were rinsed again and
exposed to rabbit anti-gB C-terminus antibody followed by an
FITC-anti-rabbit secondary conjugate (green; total gB). Therefore,
internalized gB is both green and red (yellow vacuoles), PM gB is blue,
red, and green (white PM staining), and gB that was absent from the PM
during the 30-min mouse anti-gB N-terminus antibody exposure is green.
Magnifications, 473×.
|
|
 |
DISCUSSION |
Here we demonstrate that phosphorylation of HCMV gB in HF and U373
cells occurs in vivo only at the CKII site in the cytoplasmic domain
and that the phosphorylation state of the gB carboxy-terminal tail is
one of the important determinants for intracellular trafficking. We
also show that gB plasma membrane expression occurs in a cell-specific manner. Specifically, the steady-state expression of gB at the cell
surface in U373 cells is dependent on the phosphorylation state of
Ser900 in the gB cytoplasmic tail. Cell-specific
differences were shown to be associated with a tautomycin-sensitive
phosphatase, not with CKII activity. In addition, our results suggest
that gB trafficks to the PM in a dephosphorylation-independent manner. Therefore, the cell-specific difference in the steady-state expression of gB at the cell surface is the result of the state of phosphorylation of Ser900, which affects either the internalization rate of
gB from the PM or recycling to the PM. Finally, gB accumulates in cytoplasmic vacuoles upon leaving the PM. These observations suggest that formation of these vacuoles may be required for HCMV capsid envelopment.
The initial finding that gB was not on the PM of HCMV-infected U373
cells is in contrast to previous findings of gB expression in
constitutively expressing stable U373 cell lines (55, 59). The difference may be explained either by the overexpression of the
glycoprotein in the cell line or by the use of fluorescence-activated cell sorter analysis rather than immunofluorescence to detect gB. In
any event, our data are in agreement that gB is present on the U373 PM
but the steady-state amount varies greatly depending on the cell type
due to the presence of a charged residue at Ser900.
The processes involved in HCMV assembly and egress are controversial
and are considered to involve mechanisms similar to those used by other
herpesviruses (35). The herpesvirus model suggests that
nucleocapsids assembled in the nucleus acquire a temporary envelope by
budding through the nuclear membrane, followed by deenvelopment at the
outer nuclear membrane (2, 39). Transport across the nuclear
membrane is hypothesized to be mediated by gB and gH localization to
the nuclear membrane. While the latter hypothesis may be correct,
experiments have not been reported which differentiate gB localization
at the nuclear membrane from localization at the rough endoplasmic
reticulum, which are in close proximity. This issue may be resolved by
using double-label experiments with viral envelope antibodies in
combination with antibodies to rough endoplasmic reticulum or nuclear
membrane markers. The final HCMV envelope is proposed to be acquired in the trans-Golgi network (TGN), since this step is sensitive
to brefeldin A treatment (12). This latter step is logical,
since several groups of viruses acquire their envelope glycoproteins in
the secretory pathway during assembly (44, 53).
The cytoplasmic tails of a number of viral glycoproteins that enter the
secretory pathway have been shown to contain selective trafficking
signals, which direct proteins to different cellular compartments
(10, 29, 31, 42, 46, 60). Surface expression of viral
glycoproteins is determined by the cellular steady-state expression of
the protein, transport to the PM, and rates of internalization of
proteins from the cell surface. Internalization occurs through both
clathrin-dependent and -independent pathways. The C-terminal domains of
several membrane proteins contain amino acid motifs which constitute
internalization signals. These proteins include furin, low-density
lipoprotein receptor, transferrin receptor, polymeric Ig receptor,
epidermal growth factor receptor, varicella-zoster virus Fc receptor
gE, and the simian immunodeficiency virus transmembrane protein gp41
(3, 10, 26, 29, 31, 36, 42, 46, 58, 60). A comparison of the
sequences of these proteins indicates that a common structure rather
than sequence is necessary for internalization. The varicella-zoster
virus gE envelope glycoprotein contains two TGN-targeting sequences in
the cytoplasmic domain, an AYRV motif and an acidic amino acid cluster
(60). The presence of either of these sequences is
sufficient to cause internalization of protein on the PM and targeting
to the TGN. The Tyr-dependent motif in the cytoplasmic tail of the
simian immunodeficiency virus gp41 transmembrane protein is another
example of an internalization signal that regulates glycoprotein
expression at the cell surface (42). The signals for
internalization of HCMV gB are unknown.
Protein localization to subcellular compartments may also be influenced
by secondary modifications that occur in a cell-type-specific manner.
For example, the glycoproteins produced by Sindbis virus are modified
in the secretory pathway of both vertebrate and insect cells but have
cell-specific trafficking patterns which affect the subcellular
location of virus assembly (43). Thus, in vertebrate cells,
viral assembly and budding occurs at the PM. In contrast, in insect
cells, virus buds into intracellular vacuoles, which fuse with the PM
and release virus into the extracellular fluid. The Sindbis virus
glycoproteins are transiently phosphorylated; inhibitors of
phosphorylation prevent the production of infectious virus
(30). These observations suggest that the phosphorylation state of Sindbis virus glycoproteins may determine either
glycoprotein trafficking or viral assembly. Similarly, HCMV also
demonstrates cell specificity for virus release, and the
phosphorylation of gB may determine this event.
In summary, understanding the mechanisms involved in gB trafficking may
be important in determining the mechanisms of viral envelopment and
intracellular sequestration. Future work will determine the importance
of gB expression on the PM in these processes.
 |
ACKNOWLEDGMENTS |
We thank Sandy Schmid, Shaun Molloy, and Gary Thomas for
technical advice and helpful discussion.
This work was supported by Public Health Service grant AI 21640 from
the National Institutes of Health (to J.A.N.), the Molecular Hematology
Training Program NIH NRSA Training Award (to K.N.F.), and the Knut and
Alice Wallenbergs Foundation (to C.S.-N.). C.S.-N. is a scholar of the
Wenner-Gren Foundation, Sweden.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Microbiology and Immunology, Oregon Health Sciences
University, L220, 3181 SW Sam Jackson Park Rd., Portland, OR 97201. Phone: (503) 494-7769. Fax: (503) 494-2441. E-mail:
nelsonj{at}ohsu.edu.
Present address: Department of Biosciences at Novum, Karolinska
Institute, Huddinge, Sweden.
 |
REFERENCES |
| 1.
|
Bogner, E.,
B. Anheier,
F. Offner,
C. Smuda,
M. Reschke,
M. Eickmann, and K. Radsak.
1997.
Nuclear translocation of mutagenized forms of human cytomegalovirus glycoprotein B (gpUL55).
J. Gen. Virol.
78:1647-1651[Abstract].
|
| 2.
|
Bogner, E.,
M. Reschke,
B. Reis,
E. Reis,
W. Britt, and K. Radsak.
1992.
Recognition of compartmentalized intracellular analogs of glycoprotein H of human cytomegalovirus.
Arch. Virol.
126:67-80[Medline].
|
| 3.
|
Bos, K.,
C. Wraight, and K. K. Stanely.
1993.
TGN38 is maintained in the trans-Golgi network by a tyrosine-containing motif in the cytoplasmic domain.
EMBO J.
12:2219-2228[Medline].
|
| 4.
|
Bresnahan, P. A.,
R. Leduc,
L. Thomas,
J. Thorner,
H. I. Gibson,
A. J. Brake,
P. J. Barr, and G. Thomas.
1990.
Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo.
J. Cell Biol.
111:2851-2859[Abstract/Free Full Text].
|
| 5.
|
Britt, W. J.
1984.
Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus.
Virology
135:369-378[Medline].
|
| 6.
|
Britt, W. J., and L. G. Vugler.
1992.
Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).
J. Virol.
66:6747-6754[Abstract/Free Full Text].
|
| 7.
|
Damke, H.,
T. Baba,
D. Warnock, and S. Schmid.
1994.
Induction of mutant dynamin specifically blocks endocytic coated vesicle formation.
J. Cell Biol.
127:915-934[Abstract/Free Full Text].
|
| 8.
|
Dankner, W. M.,
J. A. McCutchan,
D. D. Richman,
K. Hirata, and S. A. Spector.
1990.
Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization.
J. Infect. Dis.
161:31-36[Medline].
|
| 9.
|
Diosi, P.,
E. Moldovan, and N. Tomescu.
1969.
Latent cytomegalovirus infection in blood donors.
Br. Med. J.
4:660-662.
|
| 10.
|
Doyle, C.,
M. G. Roth,
J. Sambrook, and M. J. Gething.
1985.
Mutations in the cytoplasmic domain of the influenza virus hemagglutinin affect different stages of intracellular transport.
J. Cell Biol.
100:704-714[Abstract/Free Full Text].
|
| 11.
|
Dudding, L. R., and H. M. Garnett.
1987.
Interaction of strain AD169 and a clinical isolate of cytomegalovirus with peripheral monocytes: the effect of lipopolysaccharide stimulation.
J. Infect. Dis.
155:891-896[Medline].
|
| 12.
|
Eggers, M.,
E. Bogner,
B. Agricola,
H. F. Kern, and K. Radsak.
1992.
Inhibition of human cytomegalovirus maturation by brefeldin A.
J. Gen. Virol.
73:2679-2692[Abstract/Free Full Text].
|
| 13.
|
Einhorn, L., and A. Öst.
1984.
Cytomegalovirus infection of human blood cells.
J. Infect. Dis.
149:207-214[Medline].
|
| 14.
|
Fish, K. N.,
W. Britt, and J. A. Nelson.
1996.
A novel mechanism for persistence of human cytomegalovirus in macrophages.
J. Virol.
70:1855-1862[Abstract].
|
| 15.
|
Fish, K. N.,
A. S. Depto,
A. V. Moses,
W. Britt, and J. A. Nelson.
1995.
Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages.
J. Virol.
69:3737-3743[Abstract].
|
| 16.
|
Fish, K. N.,
C. Soderberg-Naucler,
L. Mills,
S. Stenglein, and J. A. Nelson.
1998.
Human cytomegalovirus persistently infects aortic endothelial cells.
J. Virol.
72:5661-5668[Abstract/Free Full Text].
|
| 17.
|
Fish, K. N.,
S. G. Stenglein,
C. Ibanez, and J. A. Nelson.
1995.
Cytomegalovirus persistence in macrophages and endothelial cells.
Scand. J. Infect. Dis. Supple.
99:34-40.
|
| 18.
|
Foucar, E.,
K. Mukai,
K. Foucar,
D. E. Sutherland, and C. T. Van Buren.
1981.
Colon ulceration in lethal cytomegalovirus infection.
Am. J. Clin. Pathol.
76:788-801[Medline].
|
| 19.
|
Gnann, J., Jr.,
J. Ahlmen,
C. Svalander,
L. Olding,
M. B. Oldstone, and J. A. Nelson.
1988.
Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus.
Am. J. Pathol.
132:239-248[Abstract].
|
| 20.
|
Gretch, D. R.,
B. Kari,
L. Rasmussen,
R. C. Gehrz, and M. F. Stinski.
1988.
Identification and characterization of three distinctive families of glycoprotein complexes present in the envelopes of human cytomegalovirus.
J. Virol.
62:875-881[Abstract/Free Full Text].
|
| 21.
|
Hayflick, J. S.,
W. J. Wolfgang,
M. A. Forte, and G. Thomas.
1992.
A unique Kex2-like endoprotease from Drosophila melanogaster is expressed in the central nervous system during early embryogenesis.
J. Neurosci.
12:705-717[Abstract].
|
| 22.
|
Ho, M.
1991.
Cytomegalovirus: biology and infection.
Plenum Medical Book Co., New York, N.Y.
|
| 23.
|
Howell, C. L.,
M. J. Miller, and W. J. Martin.
1979.
Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods.
J. Clin. Microbiol.
10:533-537[Abstract/Free Full Text].
|
| 24.
|
Hunter, E., and R. Swanstrom.
1990.
Retrovirus envelope glycoproteins.
Curr. Top. Microbiol. Immunol.
157:187-253[Medline].
|
| 25.
|
Ibanez, C. E.,
R. Schrier,
P. Ghazal,
C. Wiley, and J. A. Nelson.
1991.
Human cytomegalovirus productively infects primary differentiated macrophages.
J. Virol.
65:6581-6588[Abstract/Free Full Text].
|
| 26.
|
Jones, B. G.,
L. Thomas,
S. S. Molloy,
C. D. Thulin,
M. D. Fry,
K. A. Walsh, and G. Thomas.
1995.
Intracellular trafficking of furin is modulated by the phosphorylation state of a casein kinase II site in its cytoplasmic tail.
EMBO J.
14:5869-5883[Medline].
|
| 27.
|
Jupp, R.,
S. Hoffmann,
A. Depto,
R. M. Stenberg,
P. Ghazal, and J. A. Nelson.
1993.
Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box.
J. Virol.
67:5595-5604[Abstract/Free Full Text].
|
| 28.
|
Kondo, K.,
H. Kaneshima, and E. S. Mocarski.
1994.
Human cytomegalovirus latent infection of granulocyte-macrophage progenitors.
Proc. Nat. Acad. Sci. USA
91:11879-11883[Abstract/Free Full Text].
|
| 29.
|
Lazarovits, J., and M. Roth.
1988.
A single amino acid change in the cytoplasmic domain allows influenza virus hemagglutinin to be endocytosed through coated pits.
Cell
53:743-752[Medline].
|
| 30.
|
Liu, N., and D. T. Brown.
1993.
Phosphorylation and dephosphorylation events play critical roles in Sindbis virus maturation.
Virology
196:703-711[Medline].
|
| 31.
|
Lydy, S. L., and R. W. Compans.
1993.
Role of the cytoplasmic domains of viral glycoproteins in antibody-induced cell surface mobility.
J. Virol.
67:6289-6294[Abstract/Free Full Text].
|
| 32.
|
Maciejewski, J. P.,
E. E. Bruening,
R. E. Donahue,
E. S. Mocarski,
N. S. Young, and S. C. St Jeor.
1992.
Infection of hematopoietic progenitor cells by human cytomegalovirus.
Blood
80:170-178[Abstract/Free Full Text].
|
| 33.
|
Maciejewski, J. P.,
E. E. Bruening,
R. E. Donahue,
S. E. Sellers,
C. Carter,
N. S. Young, and S. St. Jeor.
1993.
Infection of mononucleated phagocytes with human cytomegalovirus.
Virology
195:327-336[Medline].
|
| 34.
|
Minton, E. J.,
C. Tysoe,
J. H. Sinclair, and J. G. Sissons.
1994.
Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow.
J. Virol.
68:4017-4021[Abstract/Free Full Text].
|
| 35.
|
Mocarski, E. S. J.
1996.
Cytomegaloviruses and their replication, 3rd ed., vol. 2.
Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 36.
|
Molloy, S. S.,
L. Thomas,
J. K. VanSlyke,
P. E. Stenberg, and G. Thomas.
1994.
Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface.
EMBO J.
13:18-33[Medline].
|
| 37.
|
Norais, N.,
J. A. Hall,
L. Gross,
D. Tang,
S. Kaur,
S. H. Chamberlain,
R. I. Burke, and F. Marcus.
1996.
Evidence for a phosphorylation site in cytomegalovirus glycoprotein gB.
J. Virol.
70:5716-5719[Abstract/Free Full Text].
|
| 38.
|
Pereira, L.,
M. Hoffman,
D. Gallo, and N. Cremer.
1982.
Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants.
Infect. Immun.
36:924-932[Abstract/Free Full Text].
|
| 39.
|
Radsak, K.,
K. Brucher,
W. Britt,
H. Shiou,
D. Schneider, and A. Kollert.
1990.
Nuclear compartmentation of gB of human cytomegalovirus.
Virology
177:515-522[Medline].
|
| 40.
|
Rice, G. P.,
R. D. Schrier, and M. B. Oldstone.
1984.
Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products.
Proc. Natl. Acad. Sci. USA
81:6134-6138[Abstract/Free Full Text].
|
| 41.
|
Rinaldo, C., Jr.,
P. H. Black, and M. S. Hirsch.
1977.
Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus.
J. Infect. Dis.
136:667-678[Medline].
|
| 42.
|
Sauter, M. M.,
A. Pelchen-Matthews,
R. Bron,
M. Marsh,
C. C. LaBranche,
P. J. Vance,
J. Romano,
B. S. Haggarty,
T. K. Hart,
W. M. Lee, and J. A. Hoxie.
1996.
An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface.
J. Cell Biol.
132:795-811[Abstract/Free Full Text].
|
| 43.
|
Schlesinger, S., and M. Schlesinger.
1996.
Togaviridae: the viruses and their replication, p. 825-841.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed., vol. 1. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 44.
|
Schmelz, M.,
B. Sodeik,
M. Ericsson,
E. J. Wolffe,
H. Shida,
G. Hiller, and G. Griffiths.
1994.
Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans-Golgi network.
J. Virol.
68:130-170[Abstract/Free Full Text].
|
| 45.
|
Schrier, R. D.,
J. A. Nelson, and M. B. Oldstone.
1985.
Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection.
Science
230:1048-1051[Abstract/Free Full Text].
|
| 46.
|
Shafer, W.,
A. Stroh,
S. Berghofer,
J. Seiler,
M. Vey,
M. F. Kern,
H. D. Klenk, and W. Garten.
1995.
Two independent targeting signals in the cytoplasmic domain determine trans Golgi network localization and endosomal trafficking of the proprotein convertase furin.
EMBO J.
14:2424-2435[Medline].
|
| 47.
|
Sinzger, C.,
A. Grefte,
B. Plachter,
A. S. Gouw,
T. H. The, and G. Jahn.
1995.
Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues.
J. Gen. Virol.
76:741-750[Abstract/Free Full Text].
|
| 48.
|
Sinzger, C.,
H. Muntefering,
T. Loning,
H. Stoss,
B. Plachter, and G. Jahn.
1993.
Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining.
Virchows Arch. A
423:249-256.
|
| 49.
|
Sinzger, C.,
B. Plachter,
A. Grefte,
T. H. The, and G. Jahn.
1996.
Tissue macrophages are infected by human cytomegalovirus in vivo.
J. Infect. Dis.
173:240-245[Medline].
|
| 50.
|
Sinzger, C.,
B. Plachter,
S. Stenglein, and G. Jahn.
1993.
Immunohistochemical detection of viral antigens in smooth muscle, stromal, and epithelial cells from acute human cytomegalovirus gastritis.
J. Infect. Dis.
167:1427-1432[Medline].
|
| 51.
|
Söderberg, C.,
S. Larsson,
S. Bergstedt-Lindqvist, and E. Möller.
1993.
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection.
J. Virol.
67:3166-3175[Abstract/Free Full Text].
|
| 52.
|
Spaete, R. R.,
R. M. Thayer,
W. S. Probert,
F. R. Masiarz,
S. H. Chamberlain,
L. Rasmussen,
T. C. Merigan, and C. Pachl.
1988.
Human cytomegalovirus straine Towne glycoprotein B is processed by proteolytic cleavage.
Virology
167:207-225[Medline].
|
| 53.
|
Sturman, L. S., and K. V. Holmes.
1983.
The molecular biology of coronaviruses.
Adv. Virus Res.
28:35-112[Medline].
|
| 54.
|
Taylor-Wiedeman, J.,
J. G. Sissons,
L. K. Borysiewicz, and J. H. Sinclair.
1991.
Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells.
J. Gen. Virol.
72:2059-2064[Abstract/Free Full Text].
|
| 55.
|
Tugizov, S.,
Y. Wang,
I. Qadri,
D. Navarro,
E. Maidji, and L. Pereira.
1995.
Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation.
Virology
209:580-591[Medline].
|
| 56.
|
Turtinen, L. W.,
R. Saltzman,
M. C. Jordan, and A. T. Haase.
1987.
Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization.
Microb. Pathog.
3:287-297[Medline].
|
| 57.
|
VanSlyke, J. K.,
L. Thomas, and G. Thomas.
1995.
In
I. A. Smith (ed.), Methods in neuroscience, p. 45-64.
Academic Press, Inc., Orlando, Fla.
|
| 58.
|
Voorhees, P.,
E. Diegnan,
E. van Donselaar,
J. Humphrey,
M. S. Marks,
P. J. Peters, and J. S. Bonifacino.
1995.
An acid sequence within the cytoplasmic tail domain of furin functions as a determinant of trans-Golgi network localization and internalization from the cell surface.
EMBO J.
14:4961-4975[Medline].
|
| 59.
|
Zheng, Z.,
E. Maidji,
S. Tugizov, and L. Pereira.
1996.
Mutations in the carboxyl-terminal hydrophobic sequence of human cytomegalovirus glycoprotein B alter transport and protein chaperone binding.
J. Virol.
70:8029-8040[Abstract].
|
| 60.
|
Zhu, Z.,
Y. Hao,
M. D. Gershon,
R. T. Ambron, and A. A. Gershon.
1996.
Targeting of glycoprotein I (gE) of varicella-zoster virus to the trans-Golgi network by an AYRV sequence and an acidic amino acid-rich patch in the cytosolic domain of the molecule.
J. Virol.
70:6563-6575[Abstract/Free Full Text].
|
J Virol, August 1998, p. 6657-6664, Vol. 72, No. 8
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nogalski, M. T., Podduturi, J. P., DeMeritt, I. B., Milford, L. E., Yurochko, A. D.
(2007). The Human Cytomegalovirus Virion Possesses an Activated Casein Kinase II That Allows for the Rapid Phosphorylation of the Inhibitor of NF-{kappa}B, I{kappa}B{alpha}. J. Virol.
81: 5305-5314
[Abstract]
[Full Text]
-
Wiertz, E. J., Devlin, R., Collins, H. L., Ressing, M. E.
(2007). Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation. J. Virol.
81: 4389-4396
[Full Text]
-
Maresova, L., Pasieka, T. J., Homan, E., Gerday, E., Grose, C.
(2005). Incorporation of Three Endocytosed Varicella-Zoster Virus Glycoproteins, gE, gH, and gB, into the Virion Envelope. J. Virol.
79: 997-1007
[Abstract]
[Full Text]
-
Mavinakere, M. S., Colberg-Poley, A. M.
(2004). Dual targeting of the human cytomegalovirus UL37 exon 1 protein during permissive infection. J. Gen. Virol.
85: 323-329
[Abstract]
[Full Text]
-
Jones, T. R., Lee, S.-W.
(2004). An Acidic Cluster of Human Cytomegalovirus UL99 Tegument Protein Is Required for Trafficking and Function. J. Virol.
78: 1488-1502
[Abstract]
[Full Text]
-
Beitia Ortiz de Zarate, I., Kaelin, K., Rozenberg, F.
(2004). Effects of Mutations in the Cytoplasmic Domain of Herpes Simplex Virus Type 1 Glycoprotein B on Intracellular Transport and Infectivity. J. Virol.
78: 1540-1551
[Abstract]
[Full Text]
-
Jarvis, M. A., Jones, T. R., Drummond, D. D., Smith, P. P., Britt, W. J., Nelson, J. A., Baldick, C. J.
(2004). Phosphorylation of Human Cytomegalovirus Glycoprotein B (gB) at the Acidic Cluster Casein Kinase 2 Site (Ser900) Is Required for Localization of gB to the trans-Golgi Network and Efficient Virus Replication. J. Virol.
78: 285-293
[Abstract]
[Full Text]
-
Crump, C. M., Hung, C.-H., Thomas, L., Wan, L., Thomas, G.
(2003). Role of PACS-1 in Trafficking of Human Cytomegalovirus Glycoprotein B and Virus Production. J. Virol.
77: 11105-11113
[Abstract]
[Full Text]
-
Homman-Loudiyi, M., Hultenby, K., Britt, W., Soderberg-Naucler, C.
(2003). Envelopment of Human Cytomegalovirus Occurs by Budding into Golgi-Derived Vacuole Compartments Positive for gB, Rab 3, Trans-Golgi Network 46, and Mannosidase II. J. Virol.
77: 3191-3203
[Abstract]
[Full Text]
-
Hegde, N. R., Tomazin, R. A., Wisner, T. W., Dunn, C., Boname, J. M., Lewinsohn, D. M., Johnson, D. C.
(2002). Inhibition of HLA-DR Assembly, Transport, and Loading by Human Cytomegalovirus Glycoprotein US3: a Novel Mechanism for Evading Major Histocompatibility Complex Class II Antigen Presentation. J. Virol.
76: 10929-10941
[Abstract]
[Full Text]
-
Kenyon, T. K., Cohen, J. I., Grose, C.
(2002). Phosphorylation by the Varicella-Zoster Virus ORF47 Protein Serine Kinase Determines whether Endocytosed Viral gE Traffics to the trans-Golgi Network or Recycles to the Cell Membrane. J. Virol.
76: 10980-10993
[Abstract]
[Full Text]
-
Slobedman, B., Mocarski, E. S., Arvin, A. M., Mellins, E. D., Abendroth, A.
(2002). Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood
100: 2867-2873
[Abstract]
[Full Text]
-
Favoreel, H. W., Van Minnebruggen, G., Nauwynck, H. J., Enquist, L. W., Pensaert, M. B.
(2002). A Tyrosine-Based Motif in the Cytoplasmic Tail of Pseudorabies Virus Glycoprotein B Is Important for both Antibody-Induced Internalization of Viral Glycoproteins and Efficient Cell-to-Cell Spread. J. Virol.
76: 6845-6851
[Abstract]
[Full Text]
-
Jarvis, M. A., Fish, K. N., Soderberg-Naucler, C., Streblow, D. N., Meyers, H. L., Thomas, G., Nelson, J. A.
(2002). Retrieval of Human Cytomegalovirus Glycoprotein B from Cell Surface Is Not Required for Virus Envelopment in Astrocytoma Cells. J. Virol.
76: 5147-5155
[Abstract]
[Full Text]
-
Strive, T., Borst, E., Messerle, M., Radsak, K.
(2002). Proteolytic Processing of Human Cytomegalovirus Glycoprotein B Is Dispensable for Viral Growth in Culture. J. Virol.
76: 1252-1264
[Abstract]
[Full Text]
-
Colberg-Poley, A. M., Patel, M. B., Erezo, D. P. P., Slater, J. E.
(2000). Human cytomegalovirus UL37 immediate-early regulatory proteins traffic through the secretory apparatus and to mitochondria. J. Gen. Virol.
81: 1779-1789
[Abstract]
[Full Text]
-
Brideau, A. D., Eldridge, M. G., Enquist, L. W.
(2000). Directional Transneuronal Infection by Pseudorabies Virus Is Dependent on an Acidic Internalization Motif in the Us9 Cytoplasmic Tail. J. Virol.
74: 4549-4561
[Abstract]
[Full Text]
-
Wisner, T., Brunetti, C., Dingwell, K., Johnson, D. C.
(2000). The Extracellular Domain of Herpes Simplex Virus gE Is Sufficient for Accumulation at Cell Junctions but Not for Cell-to-Cell Spread. J. Virol.
74: 2278-2287
[Abstract]
[Full Text]
-
Singh, J., Compton, T.
(2000). Characterization of a Panel of Insertion Mutants in Human Cytomegalovirus Glycoprotein B. J. Virol.
74: 1383-1392
[Abstract]
[Full Text]
-
Sanchez, V., Greis, K. D., Sztul, E., Britt, W. J.
(2000). Accumulation of Virion Tegument and Envelope Proteins in a Stable Cytoplasmic Compartment during Human Cytomegalovirus Replication: Characterization of a Potential Site of Virus Assembly. J. Virol.
74: 975-986
[Abstract]
[Full Text]
-
Plafker, S. M., Woods, A. S., Gibson, W.
(1999). Phosphorylation of Simian Cytomegalovirus Assembly Protein Precursor (pAPNG.5) and Proteinase Precursor (pAPNG1): Multiple Attachment Sites Identified, Including Two Adjacent Serines in a Casein Kinase II Consensus Sequence. J. Virol.
73: 9053-9062
[Abstract]
[Full Text]
-
Tugizov, S., Maidji, E., Xiao, J., Pereira, L.
(1999). An Acidic Cluster in the Cytosolic Domain of Human Cytomegalovirus Glycoprotein B Is a Signal for Endocytosis from the Plasma Membrane. J. Virol.
73: 8677-8688
[Abstract]
[Full Text]
-
Huber, M. T., Compton, T.
(1999). Intracellular Formation and Processing of the Heterotrimeric gH-gL-gO (gCIII) Glycoprotein Envelope Complex of Human Cytomegalovirus. J. Virol.
73: 3886-3892
[Abstract]
[Full Text]
-
Menotti, L., Mirandola, P., Locati, M., Campadelli-Fiume, G.
(1999). Trafficking to the Plasma Membrane of the Seven-Transmembrane Protein Encoded by Human Herpesvirus 6 U51 Gene Involves a Cell-Specific Function Present in T Lymphocytes. J. Virol.
73: 325-333
[Abstract]
[Full Text]
-
Molloy, S. S., Thomas, L., Kamibayashi, C., Mumby, M. C., Thomas, G.
(1998). Regulation of Endosome Sorting by a Specific PP2A Isoform. J. Cell Biol.
142: 1399-1411
[Abstract]
[Full Text]
![]()